Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001953731 | SCV002240530 | pathogenic | not provided | 2023-03-10 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Glu300Glyfs*7) in the ARPC1B gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ARPC1B are known to be pathogenic (PMID: 27965109, 28368018, 29127144). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with ARPC1B-related conditions. ClinVar contains an entry for this variant (Variation ID: 1457394). For these reasons, this variant has been classified as Pathogenic. |
Prevention |
RCV003418257 | SCV004106267 | likely pathogenic | ARPC1B-related disorder | 2023-01-20 | criteria provided, single submitter | clinical testing | The ARPC1B c.899_944del46 variant is predicted to result in a frameshift and premature protein termination (p.Glu300Glyfs*7). To our knowledge, this variant has not been reported in the literature or in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Frameshift variants in ARPC1B are expected to be pathogenic. This variant is interpreted as likely pathogenic. |